Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
- Hepatocellular carcinoma from an immunologic perspective.Clin Cancer Res. 2013; 19: 6678-6685
- Global cancer statistics.CA Cancer J Clin. 2011; 61: 69-90
- Systemic therapies in hepatocellular carcinoma.Dig Dis. 2009; 27: 175-188
- A cancer-related protein 14-3-3zeta is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.Tumour Biol. 2014; 35: 4247-4256
- Oncolytic vaccinia virus for the treatment of cancer.Expert Opin Biol Ther. 2011; 11: 595-608
- Intravesical gene therapy: in vivo gene transfer using recombinant vaccinia virus vectors.Cancer Res. 1994; 54: 3325-3328
- Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenografts.Clin Cancer Res. 2012; 18: 2579-2590
- A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging.Mol Med. 2009; 15: 144-151
- Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.Gastroenterology. 2007; 132: 2557-2576
- Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.Gastroenterol Hepatol. 2013; 9: 1-24
- The secret ally: immunostimulation by anticancer drugs.Nat Rev Drug Discov. 2012; 11: 215-233
- Sorafenib in advanced hepatocellular carcinoma.N Engl J Med. 2008; 359: 378-390
- Systemic therapies in hepatocellular carcinoma: present and future.Future Oncol. 2013; 9: 1533-1548
- Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.Hepatology. 2006; 44: 1465-1477
- Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus.J Transl Med. 2011; 9: 36
- The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.Mol Genet Genomics. 2009; 282: 417-435
- Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.PLoS One. 2011; 6: e22069
Supported in part by training grants T 32 CA09501 (J.C.), a grant for rare diseases research from “Cycle for Survival,” a grant from Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, and The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center. The research grade virus production was supported by the Research and Development Division of Genelux Corporation.